Calorimetric and spectrophotometric investigation of PLGA nanoparticles and their complex with DNA

Journal of Thermal Analysis and Calorimetry

Volumn 99, Issue 1, 2010, Pages 337-348

  Khvedelidze, Mariam ^a,b   Mdzinarashvili, Tamaz ^a,b   Partskhaladze, Tamar ^a   Nafee, Noha ^c   Schaefer, Ulrich F ^c   Lehr, Claus Michael ^c   Schneider, Marc ^c  

^a TBILISI STATE UNIVERSITY   (Georgia)

^b Institute of Molecular Biology and Biophysics   (Georgia)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Calorimetry (DSC); Drug delivery systems; Nanoparticles; Nanoparticles DNA complexes; PLGA; Spectrophotometry

Indexed keywords

ARCHITECTURAL CHANGES; DNA COMPLEX; DRUG DELIVERY SYSTEM; DRUG DELIVERY SYSTEMS; HEAT ABSORPTION; PHYSIOLOGICAL TEMPERATURE; PLGA NANOPARTICLES; SOLVENT POLARITY; TRANSITION TEMPERATURE;

CALORIMETRY; DNA; DRUG DELIVERY; GENES; HEATING; SOLVENTS; SPECTROPHOTOMETRY;

NANOPARTICLES;

EID: 77951666598     PISSN: 13886150     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10973-009-0137-x     Document Type: Conference Paper

References (91)

1. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Del Rev. 2003; 55:329-347
2. Patil Y, Panyam J. Polymeric nanoparticles for siRNA delivery and gene silencing. Int J Pharm. 2009;367:195-203.
3. Patil Y, Toti U, Khdair A, Ma L, Panyam J. Facile single-step multifunctionalization of nanoparticles for targeted drug delivery. Biomaterials. 2009;30:859-866
4. Bejjani RA, BenEzra D, Cohen H, Rieger J, Andrieu C, Jeanny J, et al. Nanoparticles for gene delivery to retinal pigment epithelial cells. Mol Vis. 2005;11:124-132
5. Nishikawa M, Huang L. Nonviral vectors in the new millennium: Delivery barriers in gene transfer.HumGene Ther. 2001;12:861-870
6. Li S, Huang L. Nonviral gene therapy: Promises and challenges. Gene Ther. 2000;7:31-34
7. Ferber D. Gene therapy: Safer and virus-free? Science. 2001;294: 1638-1642
8. Moghimi SM, Hunter AC, Murray JC. Long circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev. 2001;53:283-318.
9. Douglas SJ, Davis SS, Illum L. Nanoparticles in drug delivery. Crit Rev Ther Drug Carrier Syst. 1987;3:233-261
10. Kreuter J, Tauber U, Illi V. Distribution and elimination of poly(methyl methacrylate) nanoparticles after subcutaneous administration to rats. J Pharm Sci. 1979;68:1443-1449
11. Hasadsri L, Kreuter J, Hattori H, Iwasaki T, George JM. Functional protein delivery into neurons using polymeric nanoparticles. J Biol Chem. 2009;284:6972-6981
12. Brown MD, Schatzlein AG, Uchegbu IF. Gene delivery with synthetic (non viral) carriers. Int J Pharm. 2001;229:1-21.
13. Fievez V, Plapied L, des Rieux A, Pourcelle V, Freichels H, Wascotte V, Vanderhaeghen ML, Jerôme C, Vanderplasschen A, Marchand-Brynaert J, Schneider YJ, Préat V. Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination. Eur J Pharm Biopharm 2009; May 3 [Epub ahead of print].
14. De S, Robinson D. Polymer relationships during preparation of chitosan-alginate and poly-l-lysine-alginate nanospheres. J Control Rel. 2003;89:101-112
15. Ricci M, Blasi P, Giovagnoli S, Perioli L, Vescovi C, Rossi C. Leucinostatin-A loaded nanospheres: Characterization and in vivo toxicity and efficacy evaluation. Int J Pharm. 2004;275:61-72.
16. Muller M, Voros J, Csucs G, Walter E, Danuser G, Textor M, et al. Surface modification of PLGA microspheres. J Biomed Mater Res. 2003;66A:55-61.
17. Feng SS, Huang GF, Mu L. Nanospheres of biodegradable polymers: A system for clinical administration of an anticancer drug paclitaxel. Ann Acad Med Singapore. 2000;29:633-639
18. Feng SS, Huang GF. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Rel. 2001;71:53-69.
19. Pan J, Feng SS. Targeting and imaging cancer cells by folate decorated, "quantum dots loaded nanoparticles of biodegradable polymers". Biomaterials. 2009;30:1176-1183
20. Mu L, Feng SS. Fabrication, characterization and in vivo release of paclitaxel (Taxol) loaded poly(lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J Control Rel. 2001;76:239-254
21. Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J Control Rel. 2002;80:129-144
22. Labhasetwar V. Nanoparticles for drug delivery. Pharm News. 1997;4:28-31.
23. Allemann E, Leroux JC, Gurny R. Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. Adv Drug Del Rev. 1998;34:171-189
24. Nishioka Y, Yoshino H. Lymphatic targeting with nanoparticulate system. Adv Drug Del Rev. 2001;47:55-64.
25. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Contr Rel. 2001;70:1-20.
26. Hariharan S, Bhardwaj V, Bala I, Sitterberg J, Bakowsky U, Kumar R. Design of estradiol loaded PLGA nanoparticulate formulations: A potential oral delivery system for hormone therapy. Pharm Res. 2006;23:184-195
27. Mittal G, Sahana D, Bhardwaj V, Kumar R. Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Rel. 2007;119: 77-85.
28. Sonaje K, Italia J, Sharma G, Bhardwaj V, Tikoo K, Kumar R. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats. Pharm Res. 2007; 24:899-908. (Pubitemid 46675391)
29. Jeon HJ, Jeong YL, Jang MK, Park YH, Nah JW. Effect of solvent on the preparation of surfactant-free poly (D, L-lactide-coglycolide) nanoparticles and norfloxacin release characteristics. Int J Pharm. 2000;207:99-108.
30. Day M, Nawaby AV, Liao X. A DSC study of the crystallization behaviour of polylactic acid and its nanocomposites. J Therm Anal Cal. 2006;86:623-629
31. Cilurzo F, Selmin F, Liberti V, Montanari L. Thermal characterization of poly(lactide-co-glycolide) microspheres containing bupivacaine base polymorphs. J Therm Anal Cal. 2005;79:9-12.
32. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Del Rev. 1997;28:5-24.
33. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials. 2000;21:2475-2490
34. Langer R. Tissue engineering: A new field and its challenges. Pharm Res. 1997;14:840-841
35. Uhrich KE, Cannizzaro SM, Langer RS, Shakeshelf KM. Polymeric systems for controlled drug release. Chem Rev. 1999; 99:3181-3198
36. Vert M, Schwach G, Engel R, Coudane J. Something new in the field of PLA/GA bioresorbable polymers? J Control Rel. 1998; 53:85-92.
37. Hans MK, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci. 2002;6: 319-327
38. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly(D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Contr Rel. 2002;82:105-114
39. Jawahar N, Eagappanath T, Venkatesh N, Jubie S, Samanta MK. Preparation and characterisation of PLGA-nanoparticles containing an anti-hypertensive agent. Int J Pharm Tech Res. 2009;1: 390-393
40. Bala I, Haribaran S, Kumar R. PLGA nanoparticles in drug delivery: The state of the art. Crit Rev Ther Drug Carrier Syst. 2004;21:387-422.
41. Hyon SH. Biodegtadable poly(lactic acid) microspheres for drug delivery systems. Yonsei Med J. 2000;41:720-734
42. Hanafusa S, Matsusue Y, Yasunaga T, Yamamuro T, Oka M, Shikinami Y, et al. Biodegradable plate fixation of rabbit femoral shaft osteotomies. A comparative study. Clin Orthop Relat Res. 1995;315:262-271
43. Matsusue Y, Hanafusa S, Yamamuro T, Shikinami Y, Lkada Y. Tissue reaction of bioabsorbable ultra high strength poly (L-lactide) rod.Along-term study in rabbits. Clin Orthop Relat Res. 1995;317: 246-253
44. Mooney DJ, Sano K, Kaufmann PM, Majahod K, Schloo B, Vacanti JP, et al. Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res. 1997;37:413-420
45. Eiselt P, Kim BS, Chacko B, Isenberg B, Peters MC, Greene KG, et al. Development of technologies aiding large-tissue engineering. Biotechnol Prog. 1998;14:134-140
46. Cartiera MS, Johnson KM, Rajendran V, Caplan MJ, Saltzman WM. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials. 2009;30:2790-2798
47. Leong KW, Langer R. Polymeric controlled drug delivery. Adv Drug Del Rev. 1987;1:33-199.
48. Park TG. Degradation of poly(lactide-co-glycolide acid) microspheres: Effect of copolymer composition. Biomaterials. 1995;16: 1123-1130
49. Hedley ML, Curley J, Urban R. Microspheres containing plasmid- encoded antigens elicit cytotoxic T-cell responses. Nat Med. 1998;4:365-368
50. Lin SY, Chen KS, Teng HH, Li MJ. In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters. J Microencapsul. 2000;17:577-586
51. Brannon-Peppas L. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int J Pharm. 1995;116:1-9.
52. Görner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E. Lidocaine-loaded biodegradable nanosperes. I. Optimization of the drug incorporation into the polymer matrix. J Contr Rel. 1999;57:259-269
53. Burkersroda FV, Schedl L, Göpferich A. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials. 2002;23:4221-4231
54. Kneuer C, Sameti M, Haltner EG, Schiestel T, Schirra H, Schmidt H, et al. Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA. Int J Pharm. 2000;196:257-261
55. Kneuer C, Sameti M, Bakowsky U, Schiestel T, Schirra H, Schmidt H, et al. A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro. Bioconjug Chem. 2000;11:926-932
56. Florence AT, Sakthivel T, Toth I. Oral uptake and translocation of a polylysine dendrimer with a lipid surface. J Control Rel. 2000;65:253-259
57. Ramaswamy C, Sakthivel T, Wilderspin AF, Florence AT. Dendriplexes and their characterization. Int J Pharm. 2003;254: 17-21.
58. Pouton CW, Lucas P, Thomas BJ, Uduehi AN, Mikroy DA, Moss SH. Polycation-DNA complexes for gene delivery: A comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. J Control Rel. 1998;53:289-299
59. Ramsay E, Gumbleton M. Polylysine and polyornithine gene transfer complexes: A study of complex stability and cellular uptake as a basis for their differential in vitro transfection efficiency. J Drug Target. 2002;10:1-9.
60. Oupicky D, Konak C, Ulbrich K, Wolfert MA, Seymour LW. DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers. J Control Rel. 2000; 65:149-171
61. Blacklock J, You YZ, Zhou QH, Mao G, Oupicky D. Gene delivery in vitro and in vivo from bioreducible multilayered polyelectrolyte films of plasmid DNA. Biomaterials. 2009;30: 939-950
62. Wagner E, Plank C, Zatloukal K, Cotton M, Birnstiel ML. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA. 1992;89:7934-7938
63. Fischer D, Bieber T, Li Y, Elsasser HP, Kissel T. A novel nonviral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res. 1999;16: 1273-1279
64. Kunath K, Harpe A, Fischer D, Petersen H, Bickel U, Voigt K, et al. Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: Comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecularweight polyethylenimine. J Control Rel. 2003;89:113-125
65. Singh M, Briones M, Ott G, O'Hagan D. Cationic microparticles: A potent delivery system for DNA vaccines. Proc Natl Acad Sci USA. 2000;97:811-816
66. Singh M, Ott G, Kazzaz J, Ugozzoli M, Briones M, Donnelly J, et al. Cationic microparticles are an effective delivery system for immune stimulatory CpG DNA. Pharm Res. 2001;18:1476-1479
67. Singh M, Vajdy M, Gardner J, Briones M, O'Hagan D. Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity. Vaccine. 2001;20:2-594.
68. Smith JG, Wedeking T, Vernachio JH, Way H, Niven RW. Characterization and in vivo testing of a heterogeneous cationic lipid-DNA formulation. Pharm Res. 1998;15:1356-1363
69. Olbrich C, Bakowsky U, Lehr C-M, Muller RH, Kneuer C. Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA. J Control Rel. 2001;77:345-355
70. Oberle V, Bakowsky U, Zuhorn IS, Hoekstra D. Lipoplex formation under equilibrium conditions reveals a three step mechanism. Biophys J. 2000;79:1447-1454
71. Mahato RI, Kawabata K, Nomura T, Takakura Y, Hashida M. Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. J Pharm Sci. 1995;84:1267-1271
72. Cui Z, Mumper RJ. Plasmid dna-entrapped nanoparticles engineered from microemulsion precursors: In vitro and in vivo evaluation. Bioconjug Chem. 2002;13:1319-1327
73. Farhood H, Serbina N, Huang L. The role of dioleyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta. 1995;1235:289-295
74. Sternberg B, Hong K, Zheng W, Papahadjopoulos D. Ultrastructural characterization of cationic liposome-DNA complexes showing enhanced stability in serum and high transfection activity in vivo. Biochim Biophys Acta. 1998;1375:23-35.
75. Meyer O, Kirpotin D, Hong K, Sternberg B, Park J, Woodle M, et al. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides. J Biol Chem. 1998;273:15621-15627
76. Behr JP, Demeneix B, Loeffler JP, Perez-Mutul J. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine- coated DNA. Proc Natl Acad USA. 1989;86:6982-6986
77. Torchilin VP, Levchenko TS, Rammohan R, Volodina N, Papahadjopoulos- Sternberg B, D'Souza GG. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci USA. 2003;100:1972-1977
78. Rädler J, Koltover I, Salditt T, Safinya C. Structure of DNA- cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science. 1997;7:810-814
79. Mrevlishvili G, Kankia B, Mdzinarashvili T, Brelidze T, Khvedelidze M, Metreveli N, et al. Liposome-DNA interaction: Microcalorimetric study. Chem Phys Lipids. 1998;94:139-143
80. Zuzzi S, Onori G, Cametti C. Thermal stability of DNA in DNAinduced dotap liposome aggregates. J Therm Anal Cal. 2008;93: 527-533
81. Cui Z, Mumper RJ. Plasmid DNA-entrapped nanoparticles engineered from microemulsion precursors: In vitro and in vivo evaluation. Bioconjug Chem. 2002;13:1319-1327
82. Kumar R, Bakowsky U, Lehr C-M. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials. 2004;25:1771-1777
83. Kumar R, Mohapatra SS, Kong X, Jena P, Bakowsky U, Lehr C-M. Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents. J Nanosci Nanotechnol. 2004;4:990-994
84. Zoua W, Liua C, Chena Z, Zhang N. Studies on bioadhesive PLGA nanoparticles: A promising gene delivery system for efficient gene therapy to lung cancer. Int J Pharm. 2009;370:187-195
85. Lira AAM, Nanclares DMA, Federman Neto A, Marchetti JM. Drug-polymer interaction in the all-trans retinoic acid release from chitosan microparticles. J Therm Anal Cal. 2007;87:899-903.
86. Haas J, Ravi K, Borchard G, Bakowsky U, Lehr C-M. Preparation and characterization of chitosan and trimethyl-chitosan-modified poly-(e-caprolactone) nanoparticles as DNA carriers. AAPS Pharm Sci Tech. 2005;6:22-30.
87. Luengo J, Weiss B, Schneider M, Ehlers A, Stracke F, König K, et al. Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol Physiol. 2006;19:190-197
88. Xu P, Gullotti E, Tong L, Highley CB, Errabelli DR, Hasan T, et al. Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. Mol Pharm. 2009;6:190-201.
89. Nafee N, Taetz S, Schneider M, Schaefer U, Lehr C-M. Chitosancoated PLGA nanoparticles for DNA/RNA delivery: Effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomedicine: Nanotechnology. Biol Med. 2007;3:173-183
90. Privalov PL, Potekhin SA. Scanning microcalorimetry in studying temperature-induced changes in proteins. Meth Enzim. 1986; 131:4-51.
91. De S, Robinson DH. Particle size and temperature effect on the physical stability of PLGA nanospheres and microspheres containing Bodipy. AAPS PharmSciTech. 2004;5:1-7.